selegiline has been researched along with hydrazine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (90.91) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kraus, P; Kuhn, W; Przuntek, H | 1 |
| Fagervall, I; Ross, SB | 1 |
| Stern, G | 1 |
| Birkmayer, GD; Birkmayer, W | 1 |
| Csanda, E; Takáts, A; Tárczy, M | 1 |
| Dostert, P; Strolin Benedetti, M | 1 |
| Kuhn, W; Przuntek, H | 1 |
| Birkmayer, W; Hars, V; Knoll, J; Marton, J; Riederer, P; Youdim, MB | 1 |
| Colpaert, FC; Janssen, PA; Niemegeers, CJ | 1 |
| Radwan, M; Wijsenbeek, H; Zemishlany, Z | 1 |
| Finberg, JP; Lamensdorf, I | 1 |
2 review(s) available for selegiline and hydrazine
| Article | Year |
|---|---|
Overview of the present state of MAO inhibitors.
Topics: Animals; Benzamides; Humans; Hydrazines; Isoquinolines; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Parkinson Disease; Phenethylamines; Piperidines; Selegiline; Structure-Activity Relationship | 1987 |
Monoamine oxidase inhibitors--current status.
Topics: Antidepressive Agents, Tricyclic; Brain Chemistry; Catecholamines; Chemical Phenomena; Chemistry; Clorgyline; Depressive Disorder; Drug Interactions; Humans; Hydrazines; Hypertension; Kinetics; Monoamine Oxidase Inhibitors; Phobic Disorders; Receptors, Adrenergic; Receptors, Serotonin; Selegiline; Tyramine | 1983 |
1 trial(s) available for selegiline and hydrazine
| Article | Year |
|---|---|
The effect of R-(-)-deprenyl in de novo Parkinson patients on combination therapy with levodopa and decarboxylase inhibitor.
Topics: Benserazide; Clinical Trials as Topic; Disability Evaluation; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Phenethylamines; Selegiline | 1987 |
8 other study(ies) available for selegiline and hydrazine
| Article | Year |
|---|---|
The effect of R-(-)-deprenyl in de novo parkinsonian patients pretreated with levodopa and decarboxylase inhibitor correlated to depression and MHPG, HIAA and HVA levels in the cerebrospinal fluid.
Topics: Benserazide; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Glycols; Homovanillic Acid; Humans; Hydrazines; Hydroxyindoleacetic Acid; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Motor Activity; Parkinson Disease; Phenethylamines; Selegiline | 1989 |
Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors.
Topics: Animals; Brain; Clorgyline; Dose-Response Relationship, Drug; Hydrazines; Hypothalamus; Iproniazid; Male; Monoamine Oxidase Inhibitors; Phenelzine; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Serotonin; Reserpine; Selegiline; Tranylcypromine | 1986 |
MPTP: clinical implications.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Basal Ganglia; Benserazide; Drug Combinations; Drug Therapy, Combination; Humans; Hydrazines; Levodopa; Parkinson Disease; Phenethylamines; Pyridines; Selegiline | 1986 |
Effect of (-)deprenyl in long-term treatment of Parkinson's disease. A 10-years experience.
Topics: Benserazide; Drug Combinations; Drug Therapy, Combination; Humans; Hydrazines; Levodopa; Parkinson Disease; Phenethylamines; Retrospective Studies; Selegiline; Time Factors | 1986 |
(-)Deprenyl in the treatment of decompensated Parkinson's disease.
Topics: Benserazide; Drug Combinations; Humans; Hydrazines; Levodopa; Movement Disorders; Parkinson Disease; Phenethylamines; Selegiline | 1986 |
Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study.
Topics: Adult; Aged; Benserazide; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Life Expectancy; Longitudinal Studies; Male; Middle Aged; Models, Biological; Phenethylamines; Retrospective Studies; Selegiline | 1985 |
Evidence that a preferred substrate for type B monoamine oxidase mediates stimulus properties of MAO inhibitors: a possible role for beta-phenylethylamine in the cocaine cue.
Topics: Animals; Cocaine; Cues; Discrimination Learning; Dose-Response Relationship, Drug; Generalization, Stimulus; Hydrazines; Male; Monoamine Oxidase Inhibitors; Nialamide; Pargyline; Rats; Selegiline; Tranylcypromine; Tryptamines | 1980 |
Reduced striatal tyrosine hydroxylase activity is not accompanied by change in responsiveness of dopaminergic receptors following chronic treatment with deprenyl.
Topics: Animals; Enzyme Inhibitors; Hydrazines; Male; Monoamine Oxidase Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Selegiline; Tyrosine 3-Monooxygenase; Visual Cortex | 1997 |